Brazilian oncology chain Oncoclinicas files for $670 million IPO



SAO PAULO, July 20 (Reuters) - Brazilian oncology clinics chain Oncoclinicas, which is backed by Goldman Sachs Group Inc GS.N , plans to raise roughly 3.5 billion reais ($671.26 million) in an initial public offering, amid a dealmaking boom in the healthcare sector in the country.

Oncoclinicas set its price per share at between 22.21 reais and 30.29 reais. The company will decide on the final price on Aug. 6.

Both the company and its shareholders plan to sell 135.1 million shares in the IPO, but this volume could increase by 35% depending on investors' demand for it.

Oncoclinicas plans to use the IPO proceeds to grow, including through mergers and acquisitions.

It posted net revenue of 2 billion reais in 2020 and a net loss of 125.2 million reais.

Goldman Sachs has a 93.5% stake in the company, but said it plans to reduce that to roughly 60% after the IPO.

Investment banking units of Goldman Sachs, Itau Unibanco, Citi, UBS BB, Santander, JPMorgan and XP will manage the offering.

($1 = 5.2141 reais)
Reporting by Carolina Mandl Editing by Paul Simao

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示: 您的資金存在風險。杠杆商品可能不適合所有客戶。 請詳細閱讀我們的風險聲明